Renal Hyperfiltration in Adolescents with Type 2 Diabetes: Physiology, Sex Differences, and Implications for Diabetic Kidney Disease

di Bjornstad, Petter, Cherney, David Z.
Pubblicato in Curr Diab Rep (2018)

Kidney Function Can Predict Pregnancy Outcomes

di Bjornstad, Petter, Cherney, David Z.I.
Pubblicato in Clin J Am Soc Nephrol (2017)

Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease

di Tuttle, Katherine R., Cherney, David Z.
Pubblicato in Clin J Am Soc Nephrol (2020)

Liraglutide for the Treatment of Type 2 Diabetes and Safety in Diabetic Kidney Disease: Liraglutide and Diabetic Kidney Disease

di Cherney, David Z., Tuttle, Katherine R.
Pubblicato in Clin J Am Soc Nephrol (2020)

DAPA-CKD: The Beginning of a New Era in Renal Protection

di Cherney, David Z.I., Verma, Subodh
Pubblicato in JACC Basic Transl Sci (2021)

Evolution of Renal Hyperfiltration and Arterial Stiffness From Adolescence Into Early Adulthood in Type 1 Diabetes

di Cherney, David Z.I., Sochett, Etienne B.
Pubblicazione 2011

Response to Comment on: Cherney and Sochett. Evolution of Renal Hyperfiltration and Arterial Stiffness From Adolescence Into Early Adulthood in Type 1 Diabetes. Diabetes Care 2011;...

di Cherney, David Z.I., Sochett, Etienne B.
Pubblicazione 2011

Novel therapies for diabetic kidney disease

di Cherney, David Z.I., Bakris, George L.
Pubblicato in Kidney Int Suppl (2011) (2018)

Sodium-Glucose Cotransporter-2 Inhibitors in Nephrology Practice: A Narrative Review

di Dubrofsky, Lisa, Srivastava, Anand, Cherney, David Z.
Pubblicato in Can J Kidney Health Dis (2020)

Update on estimation of kidney function in diabetic kidney disease

di Bjornstad, Petter, Cherney, David Z., Maahs, David M.
Pubblicato in Curr Diab Rep (2015)

Renal physiology of glucose handling and therapeutic implications

di Cherney, David Z, Kanbay, Mehmet, Lovshin, Julie A
Pubblicato in Nephrol Dial Transplant (2020)

Making a case for the combined use of SGLT2 inhibitors and GLP1 receptor agonists for cardiorenal protection

di Sridhar, Vikas S., Dubrofsky, Lisa, Boulet, Jacinthe, Cherney, David Z.
Pubblicato in J Bras Nefrol (2020)

Sex Differences in Renal Responses to Hyperglycemia, l-Arginine, and l-NMMA in Humans With Uncomplicated Type 1 Diabetes

di Cherney, David Z.I., Scholey, James W., Sochett, Etienne B.
Pubblicazione 2013

Preventing CKD in Developed Countries

di Luyckx, Valerie A., Cherney, David Z.I., Bello, Aminu K.
Pubblicato in Kidney Int Rep (2019)

Diabetic Kidney Disease in Adolescents with Type 2 Diabetes: New Insights and Potential Therapies

di Bjornstad, Petter, Cherney, David Z., Maahs, David M., Nadeau, Kristen J.
Pubblicato in Curr Diab Rep (2016)

Sodium-glucose cotransporter inhibitors in type 2 diabetes: thinking beyond glucose lowering

di Neuen, Brendon L., Cherney, David Z., Jardine, Meg J., Perkovic, Vlado
Pubblicato in CMAJ (2019)

Renal Hyperfiltration and Systemic Blood Pressure in Patients with Uncomplicated Type 1 Diabetes Mellitus

di Yang, Gary K., Maahs, David M., Perkins, Bruce A., Cherney, David Z. I.
Pubblicazione 2013

A randomized cross-over comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily tacrolimus on renal function in healthy volunteers

di Zaltzman, Jeffrey S, Lai, Vesta, Schulz, Miklos Z, Moon, Kyung-Hee, Cherney, David Z
Pubblicato in Transpl Int (2014)

Cardiorenal Protection in Diabetic Kidney Disease

di Lee, Jason F., Berzan, Ecaterina, Sridhar, Vikas S., Odutayo, Ayodele, Cherney, David Z.I.
Pubblicato in Endocrinol Metab (Seoul) (2021)

Response to Letter Regarding the Article: “Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications and Summary of Clinical Trials”...

di Lytvyn, Yuliya, Bjornstad, Petter, Udell, Jacob A., Lovshin, Julie A., Cherney, David Z.I.
Pubblicato in Circulation (2018)